In a pivotal move shaping the future of MedTech, Tyber Medical, Intech, and Resolve Surgical Technologies have merged into a unified, leading developer, designer and manufacturer of surgical devices focused on serving the needs of MedTech OEMs and patients. The new group combines world-class implant and instrumentation platforms with development and regulatory expertise to offer […]
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Despite a rocky quarter for public equities, the medtech sector showed relative resilience in Q1 2025. While broader indexes such as the S&P 500 and Nasdaq posted losses, about half of large public medtech companies managed to log gains—boosting the sector’s median performance above the market average. Volatility was sharpest in life sciences, with Tempus
PitchBook’s Q1 2025 Medtech Public Comp Sheet and Valuation Guide Read More »
You are unauthorized to view this page.
PitchBook’s Q1 2025 Medtech Public Comp Sheet and Valuation Guide Read More »
Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”; NYSE and SIX: ZBH), a global medical technology leader, announces it has completed the acquisition of Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused exclusively on the fast-growing foot and ankle orthopedic space. “We look forward to building on the strong foundation set by Albert DeCosta
Zimmer Biomet Completes Acquisition of Paragon 28 Read More »
You are unauthorized to view this page.
Zimmer Biomet Completes Acquisition of Paragon 28 Read More »
You are unauthorized to view this page.
US FTC’s GTCR-Surmodics Challenge Joined by Illinois, Minnesota Read More »
Illinois and Minnesota have joined the US Federal Trade Commission’s lawsuit seeking to block GTCR BC Holdings’ $627 million acquisition of Surmodics. Read the full article: US FTC’s GTCR-Surmodics Challenge Joined by Illinois, Minnesota // Source: https://www.mlex.com/mlex/dealrisk/articles/2327027/us-ftc-s-gtcr-surmodics-challenge-joined-by-illinois-minnesota
US FTC’s GTCR-Surmodics Challenge Joined by Illinois, Minnesota Read More »
Lexington Medical (“Lexington”), a leader in minimally-invasive surgical stapling solutions, announces a strategic investment by Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the healthcare and life sciences sectors. Founded in 2013 and headquartered in Bedford, MA, Lexington Medical designs and manufactures high-performance endoscopic stapling devices, which are proudly
Lexington Medical Secures Growth Investment from Ampersand Capital Partners Read More »
You are unauthorized to view this page.
Lexington Medical Secures Growth Investment from Ampersand Capital Partners Read More »
